Abstract
This report summarizes the results of the 3rd Joint ENCCA-WP7, EuroSarc, EEC, PROVABES, and EURAMOS European Bone Sarcoma Network Meeting, which was held at the Children’s Cancer Research Institute in Vienna, Austria on September 24–25, 2015. The joint bone sarcoma network meetings bring together European bone sarcoma researchers to present and discuss current knowledge on bone sarcoma biology, genetics, immunology, as well as results from preclinical investigations and clinical trials, to generate novel hypotheses for collaborative biological and clinical investigations. The ultimate goal is to further improve therapy and outcome in patients with bone sarcomas.
Funding Information
  • ENCCA-WP7 (The European Union’s Seventh Framework Programme (FP7/2007-2013) under the project ENCCA, grant agreement HEALTH-F2-2011-261474)
  • Eurosarc (EU project FP7-HEALTH-2011-two-stage, Project ID 278742 EUROSARC)
  • EEC (European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602856)
  • PROVABES (ERA-Net-TRANSCAN (01KT1310))
  • PanCareLife ((602030-2) EU-FP7)
  • German Cancer Aid (DKH 108128)
  • EURAMOS (The EURAMOS-group has received support from multiple funders (see Bielack et al., J Clin Oncol 33(20):2279-87, 2015))